Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study (Q46634796)
Jump to navigation
Jump to search
scientific article published in July 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study |
scientific article published in July 2005 |
Statements
1 reference
Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study (English)
1 reference
Meletios A Dimopoulos
1 reference
George Fountzilas
1 reference
Helen Gogas
1 reference
Dimitrios Bafaloukos
1 reference
Dimitrios Pectasides
1 reference
Dimosthenis V Skarlos
1 reference
Theofanis Economopoulos
1 reference
Gerasimos Aravantinos
1 reference
George Klouvas
1 reference
Haralabos P Kalofonos
1 reference
Nicholas Pavlidis
1 reference
Evangelia Razis
1 reference
Paris Kosmidis
1 reference
George Kyratzis
1 reference
1 July 2005
1 reference
1 reference
25
1 reference
4
1 reference
3103-3108
1 reference